South Georgia Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

South Georgia Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200	Closed	-$12K	–	204
2015 Q1	$12K	Hold	200	–	–	0.02%	146
2014 Q4	$12K	Hold	200	–	–	0.02%	136
2014 Q3	$11K	Hold	200	–	–	0.02%	145
2014 Q2	$10K	Hold	200	–	–	0.01%	153
2014 Q1	$11K	Hold	200	–	–	0.01%	143
2013 Q4	$8K	Buy	+200	New	+$7.88K	0.01%	181

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

South Georgia Capital's TEVA Position: Q2 2015 in Review

South Georgia Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, closing a stake of 200 shares — an estimated $12K sold.

South Georgia Capital first reported a position in TEVA in Q4 2013 and held it in 6 quarters. The position peaked at $12K in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

South Georgia Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2015 after selling out during the quarter.
South Georgia Capital sold 200 Teva Pharmaceutical Industries Limited shares in Q2 2015, an estimated $12K.
South Georgia Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 6 quarters.
South Georgia Capital's Teva Pharmaceutical Industries Limited position peaked at $12K in Q1 2015.
819 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2015.

Based on South Georgia Capital's 13F filing for Q2 2015, filed 11 Aug 2015.